【作者】 王启凤；

【导师】 沈艺峰；

【作者基本信息】 厦门大学 ， 工商管理， 2002， 硕士

【摘要】 生物制药行业作为21世纪四大高科技产业之一，因其巨大的科研价值、显著的经济和社会效益、高速的成长性以及广阔的发展前景而被誉为“朝阳产业”和“黄金产业”，各国政府、科技界和企业界都给予高度的重视和大力支持。我国已明确地将生物制药产业作为21世纪科技发展的重点和战略目标。自1992年起，我国许多公司就开始以各种形式介入生物制药领域，并在1997-1998两年，形成了轰轰烈烈的投资生物制药的高潮。几年过去了，这些投资生物制药的公司经营业绩到底如何?本文将把代表生物制药行业的优秀上市公司作为研究对象，采用以财务指标为基础的因子分析方法来综合评价生物制药上市公司的经营业绩。通过本文的分析，希望能给生物制药行业的决策者、准备在生物制药领域进行投资的企业家、政府官员以及密切关注生物制药上市公司的众多投资者提供咨讯和参考。 本文共分五章。第一章主要介绍生物制药的概念和特点、国内外生物制药行业发展概况以及我国生物制药上市公司概况。 第二章主要介绍现行企业经营绩效的评价方法以及本文将采用的企业经营业绩评价方法。 第三章主要介绍因子分析方法的概念、模型、步骤以及经营业绩评价指标的确定和本文研究数据的选取。 第四章是本文的重点，主要介绍本文的实证结果，以及生物制药上市公司经营业绩评价结果。 第五章主要介绍本文研究的结论和启示。更多还原

【Abstract】 Biopharmacy industry,as one of the four high technology industries in the 21 century,is rewarded as "the morning sun industry" and "the gold industry" for its great scientific research value,obvious economy yield,high growth speed and wide development perspective. Government,high technology field and enterprise field all pay high attention to it and support it greatly. Our country regards the biopharmacy industry as the emphasis and strategic target of the scientific technology development. Since 1999,many companies in our country started to go into the biopharmacy field by all kinds of forms,and invested the biopharmacy industry during the two years of 1997-1998. A few years passed,what is the performance of the companies which have invested the biopharmacy industry? In this dissertation,I will select the excellent public companies which represent the biopharmacy industry as the study target,use the factor analysis method based on finance measures to evaluate the public companies of the biopharmacy industry. Through the analysis in this dissertation,I hope that it can supply the message and reference for the decider in the biopharmacy industry,the enterprisers who will plan to invest the biopharmacy field,government officers and many investors who care for the public companies of the biopharmacy.This dissertation is composed of 5 chapters. The topic of the first chapter is mainly to introduce the concept and the character of the biopharmacy,the development outline of the biopharmacyindustry in our civil country and outside of our country and the public companies outline of the biopharmacy industry in our country.Chapter two mainly discusses the present evaluation methods of the corporation performance and the way which will be used in this dissertation.Chapter three mainly discusses the concept,model,steps of the factor analysis method and the selection of the evaluation measures,source of the research data.Chapter four is the emphasis of this dissertation,it focuses on the result of the performance evaluation of the biopharmacy public companies. Chapter five mainly discusses the conclusion and the revelation.更多还原